These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6747621)

  • 21. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia.
    Malhi GS; Ivanovski B; Hadzi-Pavlovic D; Mitchell PB; Vieta E; Sachdev P
    Bipolar Disord; 2007; 9(1-2):114-25. PubMed ID: 17391355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study.
    Morgan CJ; Muetzelfeldt L; Curran HV
    Addiction; 2010 Jan; 105(1):121-33. PubMed ID: 19919593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abuse of formaldehyde-laced marijuana may cause dysmnesia.
    Hawkins KA; Schwartz-Thompson J; Kahane AI
    J Neuropsychiatry Clin Neurosci; 1994; 6(1):67. PubMed ID: 8148643
    [No Abstract]   [Full Text] [Related]  

  • 24. Impairment of motor dexterity in schizophrenia assessed by a novel finger movement test.
    Midorikawa A; Hashimoto R; Noguchi H; Saitoh O; Kunugi H; Nakamura K
    Psychiatry Res; 2008 Jun; 159(3):281-9. PubMed ID: 18448171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive impairments in poly-drug ketamine users.
    Liang HJ; Lau CG; Tang A; Chan F; Ungvari GS; Tang WK
    Addict Behav; 2013 Nov; 38(11):2661-6. PubMed ID: 23899429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cognition disorders in HIV infection. Validation of a brief neuropsychological evaluation battery].
    Desi M; Seibel N; Korezlioglu J; Silvestre D; Linard F
    Encephale; 1995; 21(4):289-94. PubMed ID: 7588168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of cognitive recovery following withdrawal from long-term benzodiazepine use.
    Tata PR; Rollings J; Collins M; Pickering A; Jacobson RR
    Psychol Med; 1994 Feb; 24(1):203-13. PubMed ID: 8208885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropsychological and EEG disturbances in polydrug users.
    Grant I; Judd LL
    Am J Psychiatry; 1976 Sep; 133(9):1039-42. PubMed ID: 961924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychological/cognitive testing in an ambulatory setting.
    Jacobs EA
    Prim Care; 1982 Mar; 9(1):161-5. PubMed ID: 6918025
    [No Abstract]   [Full Text] [Related]  

  • 30. Construct validity of the Babcock Story Recall Test.
    Horner MD; Teichner G; Kortte KB; Harvey RT
    Appl Neuropsychol; 2002; 9(2):114-6. PubMed ID: 12214822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychological testing of cerebral malaria patients.
    Kastl AJ; Daroff RB; Blocker WW
    J Nerv Ment Dis; 1968 Dec; 147(6):553-61. PubMed ID: 4388796
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuropsychological deficits in 'primary' and 'secondary' non-medical drug users.
    Trites R
    Can Psychiatr Assoc J; 1975 Aug; 20(5):351-7. PubMed ID: 1182648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The detection of cognitive impairment among substance-abusing patients: the accuracy of the neuropsychological assessment battery-screening module.
    Grohman K; Fals-Stewart W
    Exp Clin Psychopharmacol; 2004 Aug; 12(3):200-7. PubMed ID: 15301637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A twin study of the neuropsychological consequences of stimulant abuse.
    Toomey R; Lyons MJ; Eisen SA; Xian H; Chantarujikapong S; Seidman LJ; Faraone SV; Tsuang MT
    Arch Gen Psychiatry; 2003 Mar; 60(3):303-10. PubMed ID: 12622664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cognitive impairment after accidental high-dose corticosteroid therapy].
    Arndt M; Kunert HJ; Sass H; Norra C
    Nervenarzt; 2004 Sep; 75(9):904-7. PubMed ID: 15378250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The abnormality of normal comparison groups: the identification of psychosis proneness and substance abuse in putatively normal research subjects.
    Butler RW; Jenkins MA; Braff DL
    Am J Psychiatry; 1993 Sep; 150(9):1386-91. PubMed ID: 8352351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High suicide risk after the development of cognitive and working memory deficits caused by cannabis, cocaine and ecstasy use.
    Pompili M; Lester D; Girardi P; Tatarelli R
    Subst Abus; 2007 Mar; 28(1):25-30. PubMed ID: 19263559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of diazepam on clinically designed FMRI.
    Ragnehed M; Håkansson I; Nilsson M; Lundberg P; Söderfeldt B; Engström M
    J Neuropsychiatry Clin Neurosci; 2007; 19(2):164-72. PubMed ID: 17431063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dependence of psychiatric diagnosis on psychological assessment.
    Loro B; Woodward JA
    J Clin Psychol; 1975 Oct; 31(4):635-9. PubMed ID: 1194415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of chronic ketamine use on frontal and medial temporal cognition.
    Chan KW; Lee TM; Siu AM; Wong DP; Kam CM; Tsang SK; Chan CC
    Addict Behav; 2013 May; 38(5):2128-32. PubMed ID: 23435274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.